As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Michael Girvigian is a radiation oncologist, assistant chief of the Department of Radiation Oncology, and co-director of the image-guided radiosurgery program for the Kaiser Permanente Los Angeles Medical Center and the Southern California Permanente Medical Group. His clinical focus is on the management of benign and malignant tumors of the brain and spine with the use of image-guided radiosurgery and radiotherapy. He also introduced the use of stereotactic body radiotherapy in the organization ...
Being active can lower your risk of getting seriously ill with COVID, regardless of your race or the chronic conditions you may have, according to research published last year in the American Journal of Preventive Medicine.
The Kaiser Permanente Southern California findings were important, impactful, and influential. As a result, the journal editors chose the research article, “Associations of Physical Inactivity and COVID-19 Outcomes Among Subgroups,” as the American Journal of Preventive Medicine 2023 Article of the Year.
Robert Sallis MD, FAAFP, FACSM, is a family medicine and sports medicine physician practicing at the Kaiser Permanente Fontana Medical Center, where he serves as director of the sports medicine fellowship program. He is a clinical professor of Family Medicine at both the Kaiser Permanente Bernard J. Tyson School of Medicine and the University ...
After 4 California cities began taxing sugar-sweetened beverages, young people in those cities had lower body mass index (BMI) compared to young people living in cities without the tax, a new study shows. “The findings of our study demonstrate that SSB (sugar-sweetened beverage) excise taxes may be associated with lower BMI percentile among youth,” ...
An analysis of Kaiser Permanente patients in California found a 33% reduced risk of dying from colorectal cancer among those completing at least one at-home fecal immunochemical test (FIT) screening. The study was published in JAMA Network Open. In 2007, Kaiser Permanente Southern California began an organized colorectal cancer screening program that includes automated outreach ...
A 2019 Kaiser Permanente program has helped patients with high levels of “bad cholesterol” start taking medications to lower their cholesterol and decrease their risk of stroke and heart attacks. This month, this SureNet Statin Start program was recognized with a prestigious UNIVANTS of Healthcare Excellence Award, and even more importantly, has significantly improved the ...
Non-muscle invasive bladder cancer patients whose treatment included the immunotherapy Bacillus Calmette-Guerin (BCG) after surgery were less likely to have their cancer recur if their diet included raw cruciferous vegetables like broccoli, a new Kaiser Permanente study found. The research, published in the Journal of Urology, analyzed data from patients enrolled in the Bladder Cancer ...
Kaiser Permanente Southern California’s legacy of research aimed at improving health and health care began in the early 1950s. In the beginning, it was physicians who used what they were seeing in the clinic to power research for the broader world. Now celebrating its 60th anniversary, the program conducts research used as evidence for national and international policymaking as well as many improvements to patient care. In this IMPACT, we share our 2023 Annual Report and the history of our program.
The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.
The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.